loadpatents
name:-0.009192943572998
name:-0.0084781646728516
name:-0.0036129951477051
Vivet; Bertrand Patent Filings

Vivet; Bertrand

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vivet; Bertrand.The latest application filed is for "novel 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives compris".

Company Profile
2.10.8
  • Vivet; Bertrand - Paris FR
  • VIVET; Bertrand - Strasbourg FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel 2,3-Dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one Derivatives Compris
App 20190292205 - El-Ahmad; Youssef ;   et al.
2019-09-26
2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof
Grant 10,253,043 - El-Ahmad , et al.
2019-04-09
Pyrimidinone derivatives as antimalarial agents
Grant 9,321,790 - El-Ahmad , et al. April 26, 2
2016-04-26
Pyrimidooxazocine derivatives as mTOR-inhibitors
Grant 9,120,812 - Braun , et al. September 1, 2
2015-09-01
Pyrimidinone Derivatives as Antimalarial Agents
App 20150183804 - El-Ahmad; Youssef ;   et al.
2015-07-02
Novel 2,3-Dihydro-1H-imidazopyrimidin-5-one and this 1,2,3,4-tetrahydropyrimidopyrimidin-6-one Derivatives Comprising a Substituted Morpholine, Preparation Thereof and Pharmaceutical Use Thereof
App 20150148328 - El-Ahmad; Youssef ;   et al.
2015-05-28
Pyrimidooxazocine Derivatives As Mtor - Inhibitors
App 20140378433 - Braun; Alain ;   et al.
2014-12-25
1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
Grant 8,846,670 - Bacque , et al. September 30, 2
2014-09-30
2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
Grant 8,828,997 - Brollo , et al. September 9, 2
2014-09-09
Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
Grant 8,722,659 - Clauss , et al. May 13, 2
2014-05-13
Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one Derivatives, Preparation Thereof, And Pharmaceutical Use Thereof
App 20120208810 - Bacque; Eric ;   et al.
2012-08-16
Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
Grant 8,242,126 - Clauss , et al. August 14, 2
2012-08-14
Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one Derivatives, Preparation Thereof, And Pharmaceutical Use Thereof
App 20120142679 - Brolio; Maurice ;   et al.
2012-06-07
Quinazolinedione Derivatives, Preparation Thereof And Various Therapeutic Uses Thereof.
App 20120115846 - CLAUSS; Annie ;   et al.
2012-05-10
Quinazolinedione Derivatives, Preparation Thereof And Therapeutic Uses Thereof
App 20100298298 - CLAUSS; Annie ;   et al.
2010-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed